A one-minute long news update, focused on COVID-19, airing before and after PBS NewsHour.
The coronavirus vaccine inching toward approval in the U.S. is desperately anticipated by weary Americans longing for a path back to normal life. But criminals are waiting, too, ready to use that desperation to their advantage, federal investigators say. A report from Associated Press and PBS NewsHour.
Renee Shaw and a panel of medical professionals discuss COVID-19's impact on Kentucky's hospitals, clinics, public health departments, and physicians. Guests include: Allison Adams, vice president for public policy at the Foundation for a Healthy Kentucky; Sarah Moyer, M.D., director of the Louisville Metro Department of Public Health and Wellness; and Jay Grider, D.O., Ph.D., chief physician executive at UK HealthCare.
Bill Bryant and a panel of journalists discuss the week's news in the commonwealth, including new restrictions on businesses, schools, and gatherings from Gov. Andy Beshear in response to rising COVID-19 rates. Guests: John Cheves, Lexington Herald-Leader; Julia Fair, Cincinnati Enquirer; Melissa Patrick, Kentucky Health News; and Joe Sonka, Louisville Courier Journal.
An overwhelming surge of the coronavirus is afflicting the United States at the very moment that extended families are considering if, and how, they can gather for the holidays. Public health experts have three words for you: “don’t do it," warning that there is currently no risk-free way to spend time indoors with the loved ones who live outside your home. A report from Courtney Vinopal and Isabella Isaacs-Thomas of PBS NewsHour.
After months of clinical trials conducted at an unprecedented pace, two pharmaceutical companies in one week have released promising early data for a pair of vaccines designed to stop the coronavirus pandemic. But even as U.S. health officials predict that millions of Americans could begin to receive vaccinations as early as next month, more research must be done. A report from PBS NewsHour's Laura Santhanam.
On Thursday, federal health officials reached an agreement with pharmacies across the U.S. to distribute free coronavirus vaccines after they are approved and become available to the public. The agreement looks ahead to a time next spring when vaccines will start to become available beyond priority groups such as health care workers and nursing home residents. A report from the Associated Press via PBS NewsHour.
As drug companies around the world rush to develop candidates for coronavirus vaccines, Pfizer announced encouraging early data from its own trials Monday. What do the preliminary results show, and even if they are borne out, what challenges remain with regard to production and distribution of the vaccine? Science correspondent Miles O’ Brien joins William Brangham to discuss.